Maria Sharapova's drug usage could end her career"I don't want to end my career this way." - Maria Sharapova admitted to testing positive for a banned performance-enhancing drug this week. However, no positive tests for meldonium have been prosecuted yet, so there is no precedent of what will happen next. Sharapova intends on continuing her career, she told reporters.
Posted by Newsweek on Tuesday, March 8, 2016
Meldonium or mildronate, also known as mildronāts, Quaterine, MET-88, and THP (for its chemical name, see below) is a limited-market cardiac drug manufactured by Grindeks, a Latvian pharmaceutical company, and distributed online in Eastern European countries as an anti-ischemia medication.[not verified in body] It is not approved by the US Food and Drug Administration, and is not legally available in the United States.[citation needed] Since January 1st 2016 it has been on the World Anti-Doping Agency (WADA) list of substances banned from use by athletes;[1] some athletes are known to have been using it before it was banned.[2]
No comments:
Post a Comment